# Central Garden & Pet Co: Form 10-Q for the period ended Jun 27, 2020

- Company: [Central Garden & Pet Co](/companies/cent.md) (CIK 887733)
- Form: 10-Q
- Filed: 2020-08-06
- Accepted by EDGAR: Aug 6, 2020, 12:48 ET
- Period: 2020-06-27
- Accession: 0000887733-20-000012
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/887733/000088773320000012/cent-20200627.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/887733/000088773320000012/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-06-27.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-03-29 to 2020-06-27 | $833.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2019-09-29 to 2020-06-27 | $2.02bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-03-29 to 2020-06-27 | $571.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2019-09-29 to 2020-06-27 | $1.42bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-03-29 to 2020-06-27 | $262.1m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2019-09-29 to 2020-06-27 | $600.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2020-03-29 to 2020-06-27 | $157.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2019-09-29 to 2020-06-27 | $427.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-03-29 to 2020-06-27 | $104.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-09-29 to 2020-06-27 | $172.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-03-29 to 2020-06-27 | $11.8m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2019-09-29 to 2020-06-27 | $33.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-03-29 to 2020-06-27 | $20.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-09-29 to 2020-06-27 | $31.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-03-29 to 2020-06-27 | $68.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-09-29 to 2020-06-27 | $107.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-03-29 to 2020-06-27 | $1.27 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2019-09-29 to 2020-06-27 | $1.95 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-03-29 to 2020-06-27 | $1.29 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2019-09-29 to 2020-06-27 | $1.97 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-03-29 to 2020-06-27 | 54,168,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-09-29 to 2020-06-27 | 54,984,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2019-09-29 to 2020-06-27 | $88.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-09-29 to 2020-06-27 | $26.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2019-09-29 to 2020-06-27 | $57.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-06-27 | $495.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-06-27 | $1.47bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-06-27 | $2.26bn | us-gaap:Assets |
| Current liabilities | at 2020-06-27 | $385.3m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2020-06-27 | $693.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-06-27 | $98.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2020-06-27 | $1.06bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 66,108 characters.

### Our Company

Central Garden & Pet Company (“Central”) is a leading innovator, producer and distributor of branded and private label products for the lawn & garden and pet supplies markets in the United States. The total annual retail sales of the pet food, treats & chews, supplies and live animal industry in 2018 was estimated by Packaged Facts and the pet industry to have been approximately $51.9 billion. We estimate the annual retail sales of the pet supplies, live animal, and treats & chews and natural pet food markets in the categories in which we participate to be approximately $27.4 billion. The total lawn and garden consumables, decorative products, live plant and outdoor cushions and pillows industry in the United States is estimated by Packaged Facts, The Freedonia Group and TechNavio to have been approximately $23.3 billion in annual retail sales in 2018, including fertilizer, pesticides, growing media, seeds, mulch, other consumables, decorative products, live plants and outdoor cushions and pillows. We estimate the annual retail sales of the lawn and garden consumables, decorative products and live plant markets in the categories in which we participate to be approximately $16.3 billion.

Our pet supplies products include products for dogs and cats, including edible bones, premium healthy edible and non-edible chews, natural dog and cat food and treats, toys, pet carriers, grooming supplies and other accessories; products for birds, small animals and specialty pets, including food, cages and habitats, toys, chews and related accessories; animal and household health and insect control products; live fish and products for fish, reptiles and other aquarium-based pets, including aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food and supplements, and information and knowledge resources; and products for horses and livestock. These products are sold under the brands including Adams™, Aqueon®, Avoderm®, C&S Products®, Cadet®, Farnam®, Four Paws®, Kaytee®, K&H Pet Products®, Nylabone®, Pinnacle®, TFH™, Zilla® as well as a number of other brands including Altosid®, Comfort Zone®, Coralife®, Interpet®, Pet Select® and Zodiac®.

Our lawn and garden supplies products include proprietary and non-proprietary grass seed; wild bird feed, bird feeders, bird houses and other birding accessories; weed, grass, and other herbicides, insecticide and pesticide products; fertilizers; and decorative outdoor lifestyle products including pottery, as well as live plants and outdoor cushions and pillows. These products are sold under the brands AMDRO®, Arden Companies™, Ironite®, Pennington®, and Sevin®, as well as a number of other brand names including Lilly Miller®, Over-N-Out®, Smart Seed® and The Rebels®.

In fiscal 2019, our consolidated net sales were $2,383 million, of which our Pet segment, or Pet, accounted for approximately $1,385 million and our Garden segment, or Garden, accounted for approximately $998 million. In fiscal 2019, our operating income was $152 million consisting of income from our Pet segment of $123 million, income from our Garden segment of $102 million and corporate expenses of $73 million.

We were incorporated in Delaware in May 1992 as the successor to a California corporation that was formed in 1955. Our executive offices are located at 1340 Treat Boulevard, Suite 600, Walnut Creek, California 94597, and our telephone number is (925) 948-4000. Our website is www.central.com. The information on our website is not incorporated by reference in this quarterly report.

### Recent Developments

#### Fiscal 2020 Third Quarter Financial Performance:

- Net sales increased $126.9 million, or 18.0%, from the prior year quarter to $833.5 million due primarily to an increase in organic sales. Pet segment sales increased $63.1 million, and Garden segment sales increased $63.8 million.
- Organic net sales increased 16.5%. Organic net sales increased 15.0% in our Pet segment and 17.9% in our Garden segment.
- Gross profit increased $42.8 million from the prior year quarter, and gross margin increased 40 basis points to 31.4%.
- Selling, general & administrative expense increased $7.0 million from the prior year quarter to $157.4 million, but declined as a percentage of net sales 240 basis points to 18.9%.
- Operating income increased $35.8 million from the prior year quarter, to $104.6 million.
- Net income in the third quarter of fiscal 2020 was $68.8 million, or $1.27 per diluted share, compared to net income of $46.2 million, or $0.80 per diluted share, in the third quarter of fiscal 2019.

#### DMC Business Unit

In November 2019, the DMC business unit in our Pet Segment experienced a fire in one of its leased properties located in Athens, Texas, which resulted in inventory, property-related and business interruption losses in the estimated range of $35 - $40 million. In April 2020, DMC experienced an additional fire in the same leased property in Athens, Texas, which resulted in inventory and property-related losses estimated to be approximately $11 million.

As of June 27, 2020, we had approximately $18 million of cost in excess of insurance proceeds related to these losses recorded on our balance sheet. Subsequent to June 27, 2020, we received insurance proceeds of approximately $9 million related to these losses. We currently believe our insurance coverage is sufficient to cover the remaining asset-related losses as well as the business interruption loss associated with this event.

#### COVID-19 Impact

We have seen the effects COVID-19 is having globally on human health, the economy and society at large. The impact of COVID-19 and measures to prevent its spread are affecting our business in a number of ways. Central is considered an essential business in most jurisdictions and almost all of our employees continue to work to meet essential needs. We have been actively addressing the COVID-19 situation and its impact on our employees and business.

From the beginning, our priority has been the safety of our employees, customers and consumers. We are proud of all that our employees have done to prioritize the health and safety of fellow team members while collaborating across the business to ensure we operate as safely and seamlessly as possible in order to provide a steady supply of product to our customers. To that end, we mobilized a cross-functional task force focused on understanding and communicating the critical issues related to the COVID-19 pandemic to mitigate the potential impacts to our people and business. Thankfully, the Central team has had a relatively small number of COVID-19 cases, and our facility maintenance of health and safety standards remains paramount.

Our teams have worked hard to do the following:

- Ensure constant communication and regularly share pertinent information around health, safety and benefits;
- Take extra precautions in our manufacturing facilities, distribution centers and offices with guidance from health authorities including social distancing, staggering shifts, procuring necessary personal protection equipment, partitions, sanitation supplies and investing in regular deep cleanings of our facilities;
- Implement travel restrictions and work-from-home policies for employees who have the ability to work from home in accordance with shelter-in-place orders; and
- Adhere to all local, state and federal requirements.

Central is experiencing varying impacts to our Garden and Pet businesses due to COVID-19. In March and April, we experienced increased demand in pet consumables due to consumers stocking up on products as the COVID-19 shelter-in-place mandates were implemented. We also saw reduced consumption on other items, such as live fish and live plants, due to in-store curtailments of foot traffic and limited access to outdoor garden departments. In May, many state and county governments began phased reopenings of their local economies. Access to outdoor garden departments resulted in increased demand for our products in May and June. Additionally, during shelter-in-place requirement periods, pet ownership significantly increased and sales continued to increase in May and June across our Pet segment portfolio. We also continue to see a rapid increase in demand in the e-commerce channel.

Our facilities have largely been exempt or partially exempt from government closure orders. We have experienced temporary closures of certain facilities, though there has not been a material impact from a plant closure to date. At some of our facilities, we have experienced reduced productivity and increased employee absences, which we expect to continue during the current pandemic. All of our manufacturing facilities and distribution centers are currently open and fully operational. We have incurred and will continue to incur additional costs including personal protective equipment and sanitation costs. The pandemic and near-term increase in demand have created operational challenges for our distribution network and impacted our ability to meet our normal fill rate standards. Our supply chain has been impacted by the rapid increase in demand and it is possible we will experience increased operational and logistics costs, although these did not have a material impact on our third fiscal quarter results. We may also experience additional disruptions in our supply chain as the pandemic continues, although we cannot reasonably estimate the potential impact or timing of those events, and we may not be able to mitigate such impact.

We believe we are financially strong and expect to be able to maintain adequate liquidity as we manage through the current economic and health environment. As of June 27, 2020, we had approximately $500 million in cash. We also have a revolving credit facility that provides up to a $400 million principal amount with an additional $200 million available with the consent of the lenders. In April 2020, we borrowed $200 million under our revolving credit facility to increase financial flexibility during the early stages of the COVID-19 pandemic. In June 2020, we repaid the $200 million. As of June 27, 2020, there were no borrowings outstanding under the Credit Facility.

We anticipate many small customers may permanently close, and we may experience collection delinquencies as customers seek to preserve liquidity. Additionally, we have small company equity method investments, intangible assets and other long-lived assets whose value is dependent on cashflows. These investments and other assets could be impacted by the COVID-19 pandemic and, therefore, may be more susceptible to impairment. Management's assessment of possible asset impairment involves numerous assumptions that involve significant judgment. As a result of the uncertainties associated with the COVID-19 pandemic, the shelter-in-place orders and the post-COVID-19 economic recovery, these factors will be even more difficult to estimate. We recorded an impairment charge of $3.6 million in our third fiscal quarter and may be required to write off certain assets that could be material in future periods.

As a result of the COVID-19 pandemic and its current impact on society and the global economic environment, our work on developing our Vision 2025 strategy has been slowed, and we now expect to communicate that strategy in late 2020.

While the unfavorable impact of COVID-19 began to adversely affect the performance in certain portions of our portfolio in March and April, in May and June we saw a large increase in demand in most areas of our portfolio which resulted in a 16.5% increase in organic net sales in our third fiscal quarter. A few of our businesses continue to experience demand or profitability headwinds. These businesses include our live animal, live plant, pet bedding and aquatics businesses. The volatility in demand, changing consumer consumption patterns and uncertainty regarding the duration of shelter-in-place requirements make it difficult to predict when more normal order patterns may return. Forecasting and planning remain challenging in the current environment. In the current uncertain environment, our employees, customers and consumers will continue to be our priority as we manage our business to deliver long-term growth.

### Results of Operations

### Three Months Ended June 27, 2020

### Compared with Three Months Ended June 29, 2019

### Net Sales

Net sales for the three months ended June 27, 2020 increased $126.9 million, or 18.0%, to $833.5 million from $706.6 million for the three months ended June 29, 2019. Organic net sales, which excludes the impact of acquisitions and divestitures in the last 12 months, increased $116.5 million, or 16.5%, as compared to the fiscal 2019 quarter. Our branded product sales increased $87.8 million, and sales of other manufacturers’ products increased $39.1 million.

Pet net sales increased $63.1 million, or 18.0%, to $413.3 million for the three months ended June 27, 2020 from $350.2 million for the three months ended June 29, 2019. The increase in net sales was due to an organic sales increase of $52.7 million and an inorganic sales increase of $10.4 million from our May 2019 acquisition of C&S Products. The increase was broad-based across our pet portfolio with the exception of our live fish business, which was impacted by the initial implementation of shelter-in-place restrictions on retail outlets and a large retailer's decision in 2019 to exit the life fish business. Increased sales in our Pet segment were aided by COVID-19 shelter-in-place restrictions which has led to increased pet ownership in dog, cat, small animals and reptiles. Also noteworthy was the acceleration of sales in the e-commerce channel. Organic sales gains were primarily in our dog and cat business, third-party products, our animal health business and in wild bird feed. Pet branded product sales increased $52.3 million, and sales of other manufacturers' products increased $10.8 million.

Garden net sales increased $63.8 million, or 17.9%, to $420.2 million for the three months ended June 27, 2020 from $356.4 million for the three months ended June 29, 2019. The increase in net sales, which was all organic, in the Garden segment was driven by increased consumer home gardening related to COVID-19 shelter-in-place restrictions, listing gains and favorable garden season weather. Net sales increased in the e-commerce channel for garden products as consumers migrated from traditional brick and mortar outlets. The increase in net sales was broad-based across our portfolio including volume-based sales increases in third-party products, controls and fertilizers, wild bird feed and grass seed. Garden branded sales increased $35.5 million, and sales of other manufacturers' products increased $28.3 million.

### Gross Profit

Gross profit for the three months ended June 27, 2020 increased $42.8 million, or 19.5%, to $262.1 million from $219.3 million for the three months ended June 29, 2019. Gross margin increased 40 basis points to 31.4% for the three months ended June 27, 2020 from 31.0% for the three months ended June 29, 2019. Both segments contributed to the gross profit increase and gross margin improvement.

In the Pet segment, both gross profit and gross margin improved. Gross profit increased due to increased sales and margin improvement. Gross margin improved due primarily to volume-related efficiencies and a favorable sales mix with increased sales in both our dog and cat business and in our animal health business.

In the Garden segment, both gross profit and gross margin increased. Gross profit improved due to the increased sales and gross margin gains. The Garden gross margin improved due primarily to increased sales and the improved margin from our controls and fertilizer business partially offset by an unfavorable business unit sales mix and a lower margin in grass seed hindered by an unfavorable customer mix and lower pricing.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $7.0 million, or 4.7%, to $157.4 million for the three months ended June 27, 2020 from $150.4 million for the three months ended June 29, 2019. Selling, general and administrative expense increased in both the Pet segment and in corporate, partially offset by a decrease in the Garden segment. As a percentage of net sales, selling, general and administrative expenses decreased to 18.9% for the three months ended June 27, 2020, compared to 21.3% in the comparable prior year quarter impacted by improved operating leverage and reduced travel and entertainment expense.

Selling and delivery expense declined to $77.4 million for the three months ended June 27, 2020 as compared to $78.4 million in the prior year quarter. The decrease was due primarily to improved overhead absorption, reduced travel and entertainment expense and reduced labor related to COVID-19 prohibitions reducing our merchandising in-store presence.

Warehouse and administrative expense increased $8.0 million, or 11.1%, to $80.0 million for the three months ended June 27, 2020 from $72.0 million for the three months ended June 29, 2019. In our operating segments, the increase was due primarily to increased labor expense in our warehouses and to a thank you bonus to our front-line workers across manufacturing, logistics and merchandising. Corporate expenses increased $4.6 million due primarily to increased variable compensation expense resulting from improved results, increased third-party expense and personal protection (PPE) costs. Corporate expenses are included within administrative expense and relate to the costs of unallocated executive, administrative, finance, legal, human resources, and information technology functions.

### Operating Income

Operating income increased $35.8 million to $104.6 million for the three months ended June 27, 2020. The increase in operating income was attributable to increased sales and an improved gross margin partially offset by increased selling, general and administrative expense. Our operating margin increased from 9.7% in the prior year quarter to 12.6% in the current year quarter due to a 40 basis point improvement in gross margin, improved overhead leverage, a 240 basis point decline in selling, general and administrative expense as a percentage of net sales, as well as COVID-19 pandemic-related reductions in promotional activity.

Pet operating income increased $15.7 million, or 44.8%, to $50.8 million for the three months ended June 27, 2020 from $35.1 million for the three months ended June 29, 2019. Pet operating income increased due to increased sales, principally organic, and increased gross profit partially offset by higher selling, general and administrative costs. Pet operating margin improved 230 basis points due to increased sales, an improved gross margin and lower selling, general and administrative expense as a percentage of net sales.

Garden operating income increased $24.7 million, or 46.5%, to $77.8 million for the three months ended June 27, 2020 from $53.1 million for the three months ended June 29, 2019. Garden operating income increased due to increased sales and gross profit and lower selling, general and administrative expense. Garden operating margin improved 360 basis points to 18.5% due to increased sales, an improved gross margin and lower selling, general and administrative expense as a percentage of sales..

Corporate operating expense increased $4.6 million, or 23.9%, to $23.9 million for the three months ended June 27, 2020 from $19.3 million for the three months ended June 29, 2019. Corporate expense increased due primarily to increased variable compensation accruals due to improved results and higher third-party expense.

### Net Interest Expense

Net interest expense for the three months ended June 27, 2020 increased $3.0 million, or 35.0%, to $11.5 million from $8.5 million for the three months ended June 29, 2019. The increase in net interest expense was due to reduced interest income resulting from a lower rate of interest earned on our cash balance during the quarter and interest expense from a temporary draw on our revolver during the quarter.

Debt outstanding on June 27, 2020 was $694.0 million compared to $693.1 million at June 29, 2019.

### Other Income (Expense)

Other income (expense) is comprised of income or losses from investments accounted for under the equity method of accounting and foreign currency exchange gains and losses. Other expense was $3.5 million for the quarter ended June 27, 2020 compared to income of $0.2 million for the quarter ended June 29, 2019, due primarily to the impairment of two investments in private companies impacted by the COVID-19 pandemic during the quarter ended June 27, 2020.

### Income Taxes

Our effective income tax rate was 22.6% for the quarter ended June 27, 2020 compared to 23.5% for the quarter ended June 29, 2019. The lower effective income tax rate in the current year quarter was due primarily to a higher stock compensation benefit in the current year quarter compared to the prior year quarter.

### Net Income and Earnings Per Share

Our net income in the third quarter of fiscal 2020 was $68.8 million, or $1.27 per diluted share, compared to net income of $46.2 million, or $0.80 per diluted share, in the third quarter of fiscal 2019.

### Nine Months Ended June 27, 2020

### Compared with Nine Months Ended June 29, 2019

### Net Sales

Net sales for the nine months ended June 27, 2020 increased $177.2 million, or 9.6%, to $2,019.5 million from $1,842.3 million for the nine months ended June 29, 2019. Organic net sales increased $118.8 million, or 6.4%, as compared to the prior year nine month period. Our branded product sales increased $110.0 million, and sales of other manufacturers’ products increased $67.2 million.

Pet net sales increased $99.3 million, or 9.7%, to $1,128.1 million for the nine months ended June 27, 2020 from $1,028.8 million for the nine months ended June 29, 2019. The increase in net sales was due to both organic growth and sales from C&S Products, which we acquired in May 2019. Organic net sales increased $69.7 million, or 6.8%. The increase was relatively broad-based across our Pet segment portfolio led by increased sales in our dog and cat and animal health businesses and sales of third-party products. These increases were partially offset by lower pet bed sales, negatively impacted in the prior quarter by a fire in one of our pet bedding facilities, and lower sales of live fish, due to a major retailer's decision in 2019 to exit the live fish business and the negative retail impact of reduced foot traffic associated with COVID-19. Pet branded sales increased $73.9 million, and sales of other manufacturer's products increased $25.4 million.

Garden net sales increased $77.9 million, or 9.6%, to $891.4 million for the nine months ended June 27, 2020 from $813.5 million for the nine months ended June 29, 2019. The increase in net sales was due to both organic growth and sales from Arden, which became 100% owned due to our acquisition of the remaining equity interest in February 2019. Organic sales increased $49.1 million, or 6.0%, due primarily to a 17.9% sales increase in the current fiscal quarter. The organic sales increase was relatively broad-based across our Garden segment portfolio, driven by increased sales of third-party products and of our control and fertilizer products. Both benefited from new listings and increased home gardening due to COVID-19 restrictions and favorable garden weather. The increase in sales was partially offset by lower grass seed sales, negatively impacted by competitive pressures and reduced promotions in our first two fiscal quarters, and our exit of the fashion decor pottery product line in mid-2019. Garden branded sales increased $36.1 million, and sales of other manufacturers’ products increased $41.8 million.

### Gross Profit

Gross profit for the nine months ended June 27, 2020 increased $44.9 million, or 8.1%, to $600.4 million from $555.5 million for the nine months ended June 29, 2019. Gross margin decreased 50 basis points to 29.7% for the nine months ended June 27, 2020 from 30.2% for the nine months ended June 29, 2019. Both operating segments contributed to the gross profit increase and gross margin decline.

In the Pet segment, gross profit increased due primarily to the acquisition of C&S Products and increased sales in dog treats and chews, partially offset by the impact of the lower sales volume in our live fish business. The decline in gross margin was due primarily to the impact of the lower sales volume in our live fish business, an unfavorable product mix in sales of dog treats and chews and increased sales of third-party products partially offset by the contribution from our acquisition of C&S Products.

In the Garden segment, both gross profit and gross margin were negatively impacted by reduced grass seed sales and our exit from the fashion décor pottery product line, which was partially offset by the positive impact of the Arden acquisition. Additionally, gross margin was negatively impacted by increased third-party sales.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $13.3 million, or 3.2%, to $427.6 million for the nine months ended June 27, 2020 from $414.3 million for the nine months ended June 29, 2019 due primarily to increased corporate expense. As a percentage of net sales, selling, general and administrative expenses decreased to 21.2% for the nine months ended June 27, 2020, from 22.5% for the comparable prior year nine month period; both operating segments contributed to the improvement.

Selling and delivery expense increased $0.8 million, or 0.4%, to $211.8 million for the nine months ended June 27, 2020 from $211.0 million for the nine months ended June 29, 2019. The increase was due primarily to increased payroll related costs and delivery expense partially offset by cost saving initiatives enacted in response to a retailer's exit from the live fish business and our exit from the fashion decor pottery product line in 2019.

Warehouse and administrative expense increased $12.5 million, or 6.1%, to $215.8 million for the nine months ended June 27, 2020 from $203.3 million for the nine months ended June 29, 2019. Increased expense from our two recent acquisitions, a bonus to our front-line workers and at corporate was partially offset by cost reduction initiatives enacted in response to a retailer’s exit from the live fish business and our exit from the fashion décor pottery product line in 2019. Corporate expense increased due primarily to increased third-party expenses, which includes costs related to the development of our Vision 2025 plan, increased variable compensation expense due to improved results, and equity compensation expense. Corporate expenses are included within administrative expense and relate to the costs of unallocated executive, administrative, finance, legal, human resource, and information technology functions.

### Operating Income

Operating income increased $31.6 million to $172.8 million for the nine months ended June 27, 2020 from $141.2 million for the nine months ended June 29, 2019. Our operating margin increased to 8.6% for the nine months ended June 27, 2020 from 7.7% for the nine months ended June 29, 2019. Increased sales of $177.2 million and a 130 basis point improvement in selling, general and administrative expense as a percentage of net sales were partially offset by a 50 basis point decline in gross margin.

Pet operating income increased $22.8 million, or 24.8%, to $114.6 million for the nine months ended June 27, 2020 from $91.8 million for the nine months ended June 29, 2019. Adjusting for the $2.5 million intangible asset impairment in fiscal 2019, operating income increased $20.3 million. The increase in operating income was due to increased net sales of $99.3 million partially offset by a decline in gross margin and an increase in selling, general and administrative expense.

Garden operating income increased $20.6 million, or 20.2%, to $122.4 million for the nine months ended June 27, 2020 from $101.8 million in the nine months ended June 29, 2019. Adjusting for the non-cash gain from the fair value remeasurement of our previously held investment interest upon our acquisition of the remaining 55% interest of Arden in the prior six month period, garden operating income increased $23.8 million. The increase in operating income was due to increased net sales of $77.9 million and lower selling, general and administrative expense partially offset by a lower gross margin.

Corporate operating expense increased $11.8 million to $64.2 million in the current nine-month period from $52.4 million in the comparable fiscal 2019 period due primarily to increased third-party expenses, increased variable compensation expense and equity compensation expense.

### Net Interest Expense

Net interest expense for the nine months ended June 27, 2020 increased $4.4 million, or 18.0%, to $29.4 million from $25.0 million for the nine months ended June 29, 2019. The increase in net interest expense was due to lower interest income from earnings on cash due to the lower rates available on our cash balance during the current year nine-month period.

Debt outstanding on June 27, 2020 was $694.0 million compared to $693.1 million as of June 29, 2019. Our average borrowing rate for the current nine-month period was 5.5% compared to the prior nine-month period of 5.8%.

### Other Income

Other income (expense) was an expense of $4.2 million for the nine-month period ended June 27, 2020 compared to income of $0.5 million for the nine-month period ended June 29, 2019, due primarily to a $3.6 million impairment of two investments in private companies impacted by the COVID-19 pandemic during the quarter ended June 27, 2020.

### Income Taxes

Our effective income tax rate was 22.4% for the nine month period ended June 27, 2020 compared to 22.3% for the nine-month period ended June 29, 2019.

### Net Income and Earnings Per Share

Our net income for the nine months ended June 27, 2020 was $107.1 million, or $1.95 per diluted share, compared to $90.3 million, or $1.56 per diluted share, for the nine months ended June 29, 2019.

### Use of Non-GAAP Financial Measures

We report our financial results in accordance with accounting principles generally accepted in the United States (GAAP). However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including EBITDA and organic sales. Management believes these non-GAAP financial measures that exclude the impact of specific items (described below) may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods.

EBITDA is defined by us as income before income tax, net other expense, net interest expense and depreciation and amortization (or operating income plus depreciation and amortization expense). We present EBITDA because we believe that EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. EBITDA is used by our management to perform such evaluation. EBITDA should not be considered in isolation or as a substitute for cash flow from operations, income from operations or other income statement measures prepared in accordance with GAAP. We believe that EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present EBITDA when reporting their results. Other companies may calculate EBITDA differently and it may not be comparable.

We have also provided organic net sales, a non-GAAP measure that excludes the impact of businesses purchased or exited in the prior 12 months, because we believe it permits investors to better understand the performance of our historical business without the impact of recent acquisitions or dispositions.

The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. We believe that the non-GAAP financial measures provide useful information to investors and other users of our financial statements by allowing for greater transparency in the review of our financial and operating performance. Management also uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating our performance, and we believe these measures similarly may be useful to investors in evaluating our financial and operating performance and the trends in our business from management's point of view. While our management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results.

Non-GAAP financial measures reflect adjustments based on the following items:

- Gains from the fair value remeasurement of previously held investment interests: we have excluded the impact of the fair value remeasurement of a previously held investment interest as it represents an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the adjustment of these gains supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.
- Asset impairment charges: we have excluded the impact of asset impairments on intangible assets as such non-cash amounts are inconsistent in amount and frequency. We believe that the adjustment of these charges supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful information to investors and management.

The non-GAAP adjustments reflect the following:

(1) During the second quarter of fiscal 2019, we recorded a preliminary, pending the finalization of the related purchase accounting, non-cash $3.2 million gain in our Garden segment from the fair value remeasurement of our previously held 45% interest in Arden upon our acquisition of the remaining 55% interest. The gain was recorded as part of selling, general and administrative costs in the condensed consolidated statements of operations.

(2) During the second quarter of fiscal 2019, we recognized a non-cash impairment charge in our Pet segment of $2.5 million related to the impairment of intangible assets caused by a retail customer exiting the live fish business. The adjustment was recorded as part of selling, general and administrative costs.

(3) During the third quarter of fiscal 2020, we recorded a non-cash impairment charge for two private company investments. The impairment was recorded as part of other income (expense).

| Operating Income Reconciliation |  | GAAP to Non-GAAP Reconciliation (in thousands) For the Nine Months Ended Consolidated June 27, 2020 | June 29, 2019 |
| --- | ---: | ---: | ---: |
| GAAP operating income |  | $172,810 | $141,205 |
| Previously held investment interest fair value remeasurement | (1) | — | (3,215) |
| Intangible asset impairment | (2) | — | 2,540 |
| Non-GAAP operating income |  | $172,810 | $140,530 |

| Pet Segment Operating Income Reconciliation |  | GAAP to Non-GAAP Reconciliation (in thousands) For the Nine Months Ended Pet June 27, 2020 | June 29, 2019 |
| --- | ---: | ---: | ---: |
| GAAP operating income |  | $114,599 | $91,805 |
| Intangible asset impairment | (2) | — | 2,540 |
| Non-GAAP operating income |  | $114,599 | $94,345 |

| Garden Segment Operating Income Reconciliation |  | GAAP to Non-GAAP Reconciliation (in thousands) For the Nine Months Ended Garden June 27, 2020 | June 29, 2019 |
| --- | ---: | ---: | ---: |
| GAAP operating income |  | $122,439 | $101,821 |
| Previously held investment interest fair value remeasurement | (1) | — | (3,215) |
| Non-GAAP operating income |  | $122,439 | $98,606 |

34

| Net Income and Diluted Net Income Per Share Reconciliation |  | GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Three Months Ended June 27, 2020 | June 29, 2019 |  | GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Nine Months Ended June 27, 2020 | June 29, 2019 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| GAAP net income attributable to Central Garden & Pet |  | $68,800 | $46,152 |  | $107,087 | $90,346 |
| Previously held investment interest fair value remeasurement | (1) | — | — | (1) | — | (3,215) |
| Intangible asset impairment | (2) | — | — | (2) | — | 2,540 |
| Investment impairments | (3) | 3,566 | — | (3) | 3,566 | — |
| Tax effect of remeasurement and impairment |  | (807) | — |  | (800) | 151 |
| Non-GAAP net income attributable to Central Garden & Pet |  | $71,559 | $46,152 |  | $109,853 | $89,822 |
| GAAP diluted net income per share |  | $1.27 | $0.80 |  | $1.95 | $1.56 |
| Non-GAAP diluted net income per share |  | $1.32 | $0.80 |  | $2.00 | $1.55 |
| Shares used in GAAP and non-GAAP diluted net earnings per share calculation |  | 54,168 | 57,985 |  | 54,984 | 57,937 |

### Organic Net Sales Reconciliation

We have provided organic net sales, a non-GAAP measure that excludes the impact of recent acquisitions and dispositions, because we believe it permits investors to better understand the performance of our historical business. We define organic net sales as net sales from our historical business derived by excluding the net sales from businesses acquired or exited in the preceding 12 months. After an acquired business has been part of our consolidated results for 12 months, the change in net sales thereafter is considered part of the increase or decrease in organic net sales.

|  | GAAP to Non-GAAP Reconciliation (in millions) For the Three Months Ended June 27, 2020 Consolidated | Percent change | Pet Segment | Percent change | Garden Segment | Percent change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Reported net sales - Q3 FY20 (GAAP) | $833.5 |  | $413.3 |  | $420.2 |  |
| Reported net sales - Q3 FY19 (GAAP) | 706.6 |  | 350.2 |  | 356.4 |  |
| Increase in net sales | 126.9 | 18.0% | 63.1 | 18.0% | 63.8 | 17.9% |
| Effect of acquisition and divestitures on increase in net sales | 10.4 |  | 10.4 |  | — |  |
| Increase in organic net sales - Q3 FY20 | $116.5 | 16.5% | $52.7 | 15.0% | $63.8 | 17.9% |

|  | GAAP to Non-GAAP Reconciliation (in millions) For the Nine Months Ended June 27, 2020 Consolidated | Percent change | Pet Segment | Percent change | Garden Segment | Percent change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Reported net sales - Q3 FY20 YTD (GAAP) | $2,019.5 |  | $1,128.1 |  | $891.4 |  |
| Reported net sales - Q3 FY19 YTD (GAAP) | 1,842.3 |  | 1,028.8 |  | 813.5 |  |
| Increase in net sales | 177.2 | 9.6% | 99.3 | 9.7% | 77.9 | 9.6% |
| Effect of acquisition and divestitures on increase in net sales | 58.4 |  | 29.6 |  | 28.8 |  |
| Increase in organic net sales - Q3 FY20 YTD | $118.8 | 6.4% | $69.7 | 6.8% | $49.1 | 6.0% |

35

| EBITDA Reconciliation | GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Three Months Ended June 27, 2020 Garden | Pet | Corp | Total |
| --- | ---: | ---: | ---: | ---: |
| Net income attributable to Central Garden & Pet | — | — | — | $68,800 |
| Interest expense, net | — | — | — | 11,471 |
| Other expense | — | — | — | 3,541 |
| Income tax expense | — | — | — | 20,291 |
| Net income attributable to noncontrolling interest | — | — | — | 537 |
| Sum of items below operating income | — | — | — | 35,840 |
| Income (loss) from operations | $77,787 | $50,760 | $(23,907) | $104,640 |
| Depreciation & amortization | 3,538 | 8,374 | 1,371 | 13,283 |
| EBITDA | $81,325 | $59,134 | $(22,536) | $117,923 |

| EBITDA Reconciliation | GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Three Months Ended June 29, 2019 Garden | Pet | Corp | Total |
| --- | ---: | ---: | ---: | ---: |
| Net income attributable to Central Garden & Pet | — | — | — | $46,152 |
| Interest expense, net | — | — | — | 8,498 |
| Other income | — | — | — | (180) |
| Income tax expense | — | — | — | 14,212 |
| Net income attributable to noncontrolling interest | — | — | — | 189 |
| Sum of items below operating income | — | — | — | 22,719 |
| Income (loss) from operations | $53,103 | $35,066 | $(19,298) | $68,871 |
| Depreciation & amortization | 3,497 | 8,083 | 1,502 | 13,082 |
| EBITDA | $56,600 | $43,149 | $(17,796) | $81,953 |

| EBITDA Reconciliation | GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Nine Months Ended June 27, 2020 Garden | Pet | Corp | Total |
| --- | ---: | ---: | ---: | ---: |
| Net income attributable to Central Garden & Pet | — | — | — | $107,087 |
| Interest expense, net | — | — | — | 29,444 |
| Other expense | — | — | — | 4,215 |
| Income tax expense | — | — | — | 31,211 |
| Net income attributable to noncontrolling interest | — | — | — | 853 |
| Sum of items below operating income | — | — | — | 65,723 |
| Income (loss) from operations | $122,439 | $114,599 | $(64,228) | $172,810 |
| Depreciation & amortization | 10,157 | 25,305 | 4,136 | 39,598 |
| EBITDA | $132,596 | $139,904 | $(60,092) | $212,408 |

36

| EBITDA Reconciliation | GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Nine Months Ended June 29, 2019 Garden | Pet | Corp | Total |
| --- | ---: | ---: | ---: | ---: |
| Net income attributable to Central Garden & Pet | — | — | — | $90,346 |
| Interest expense, net | — | — | — | 24,960 |
| Other income | — | — | — | (488) |
| Income tax expense | — | — | — | 26,031 |
| Net income attributable to noncontrolling interest | — | — | — | 356 |
| Sum of items below operating income | — | — | — | 50,859 |
| Income (loss) from operations | $101,821 | $91,805 | $(52,421) | $141,205 |
| Depreciation & amortization | 8,635 | 24,178 | 4,498 | 37,311 |
| EBITDA | $110,456 | $115,983 | $(47,923) | $178,516 |

### Inflation

Our revenues and margins are dependent on various economic factors, including rates of inflation, energy costs, consumer attitudes toward discretionary spending, currency fluctuations, and other macro-economic factors which may impact levels of consumer spending. In certain fiscal periods, we have been adversely impacted by rising input costs related to domestic inflation, particularly relating to grain and seed prices, fuel prices and the ingredients used in our garden controls and fertilizer. Rising costs in those periods have made it difficult for us to increase prices to our retail customers at a pace sufficient to enable us to maintain margins.

### Weather and Seasonality

Our sales of lawn and garden products are influenced by weather and climate conditions in the different markets we serve. Our Garden segment’s business is highly seasonal. In fiscal 2019, approximately 69% of our Garden segment’s net sales and 58% of our total net sales occurred during our second and third fiscal quarters. Substantially all of the Garden segment’s operating income is typically generated in this period, which has historically offset the operating loss incurred during the first fiscal quarter of the year.

### Liquidity and Capital Resources

We have financed our growth through a combination of internally generated funds, bank borrowings, supplier credit, and sales of equity and debt securities to the public.

Our business is seasonal and our working capital requirements and capital resources track closely to this seasonal pattern. Generally, during the first fiscal quarter, accounts receivable reach their lowest level while inventory, accounts payable and short-term borrowings begin to increase. During the second fiscal quarter, receivables, accounts payable and short-term borrowings increase, reflecting the build-up of inventory and related payables in anticipation of the peak lawn and garden selling season. During the third fiscal quarter, inventory levels remain relatively constant while accounts receivable peak and short-term borrowings start to decline as cash collections are received during the peak selling season. During the fourth fiscal quarter, inventory levels are at their lowest, and accounts receivable and payables are substantially reduced through conversion of receivables to cash.

We service two broad markets: pet supplies and lawn and garden supplies. Our pet supplies businesses involve products that have a year round selling cycle with a slight degree of seasonality. As a result, it is not necessary to maintain large quantities of inventory to meet peak demands. Our lawn and garden businesses are highly seasonal with approximately 69% of our Garden segment’s net sales occurring during the second and third fiscal quarters. This seasonality requires the shipment of large quantities of product well ahead of the peak consumer buying periods. To encourage retailers and distributors to stock large quantities of inventory, industry practice has been for manufacturers to give extended credit terms and/or promotional discounts.

### Operating Activities

Net cash provided by operating activities decreased by $3.9 million, from $92.8 million for the nine months ended June 29, 2019, to $88.9 million for the nine months ended June 27, 2020. The decrease in cash provided was due primarily to changes in our working capital accounts for the period ended June 27, 2020, as compared to the prior year period, primarily an increase in accounts receivable, due to the large increase in sales in the latter half of the third quarter, compared to the prior year.

### Investing Activities

Net cash used in investing activities decreased $33.2 million, from $65.0 million for the nine months ended June 29, 2019 to $31.8 million during the nine months ended June 27, 2020. The decrease in cash used in investing activities was due primarily to acquisition activity in the prior year, partially offset by increased capital expenditures in the current year compared to the prior year. During the second quarter of fiscal 2019, we acquired the remaining 55% interest in Arden Companies for approximately $11.0 million, and during the third quarter of fiscal 2019 we acquired C&S Products for approximately $30.0 million.

### Financing Activities

Net cash used by financing activities decreased $5.1 million, from $64.1 million for the nine months ended June 29, 2019, to $59.0 million for the nine months ended June 27, 2020. The decrease in cash used by financing activities during the current year was due primarily to our repayment of approximately $36 million of acquired long-term debt subsequent to our acquisition of Arden Companies in the prior year period, partially offset by increased open market purchases of our common stock during the current year period. During the nine months ended June 27, 2020, we repurchased approximately 0.2 million shares of our voting common stock (CENT) at an aggregate cost of approximately $6.6 million, or approximately $26.63 per share, and 1.8 million shares of our non-voting Class A common stock (CENTA) at an aggregate cost of approximately $45.7 million, or approximately $25.90 per share.

We expect that our principal sources of funds will be cash generated from our operations and, if necessary, borrowings under our $400 million asset backed revolving credit facility. Based on our anticipated cash needs, availability under our asset backed revolving credit facility and the scheduled maturity of our debt, we believe that our sources of liquidity should be adequate to meet our working capital, capital spending and other cash needs for at least the next 12 months. However, we cannot assure you that these sources will continue to provide us with sufficient liquidity and, should we require it, that we will be able to obtain financing on terms satisfactory to us, or at all.

We believe that cash flows from operating activities, funds available under our asset backed loan facility, and arrangements with suppliers will be adequate to fund our presently anticipated working capital and capital expenditure requirements for the foreseeable future. We previously estimated our capital expenditures, which are related primarily to replacements and expansion of and upgrades to plant and equipment and also investment in our continued implementation of a scalable enterprise-wide information technology platform, would be $40 million to $45 million in fiscal 2020, of which we have invested approximately $27 million year to date. As a result of the uncertainties associated with the COVID-19 pandemic, we are reevaluating the appropriate amount of our fiscal 2020 capital expenditures.

As part of our growth strategy, we have acquired a number of companies in the past, and we anticipate that we will continue to evaluate potential acquisition candidates in the future. If one or more potential acquisition opportunities, including those that would be material, become available in the near future, we may require additional external capital. In addition, such acquisitions would subject us to the general risks associated with acquiring companies, particularly if the acquisitions are relatively large.

### Total Debt

At June 27, 2020, our total debt outstanding was $694.0 million, as compared with $693.1 million at June 29, 2019.

### Senior Notes

#### $300 Million 5.125% Senior Notes

On December 14, 2017, we issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes"). We expect to use the net proceeds from the offering to finance future acquisitions and for general corporate purposes.

We incurred approximately $4.8 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes.

The 2028 Notes require semiannual interest payments on February 1 and August 1. The 2028 Notes are unconditionally guaranteed on a senior basis by our existing and future domestic restricted subsidiaries who are borrowers under or guarantors of our senior secured revolving credit facility or who guarantee the 2023 Notes.

We may redeem some or all of the 2028 Notes at any time, at our option, prior to January 1, 2023 at the principal amount plus a “make whole” premium. At any time prior to January 1, 2021, we may also redeem, at our option, up to 35% of the original aggregate principal amount of the notes with the proceeds of certain equity offerings at a redemption price of 105.125% of the principal amount of the notes. We may redeem some or all of the 2028 Notes, at our option, at any time on or after January 1, 2023 for 102.563%, on or after January 1, 2024 for 101.708%, on or after January 1, 2025 for 100.854% and on or after January 1, 2026 for 100.0%, plus accrued and unpaid interest.

The holders of the 2028 Notes have the right to require us to repurchase all or a portion of the 2028 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.

The 2028 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all financial covenants as of June 27, 2020.

#### $400 Million 6.125% Senior Notes

In November 2015, we issued $400 million aggregate principal amount of 6.125% senior notes due November 2023 (the "2023 Notes"). In December 2015, we used the net proceeds from the offering, together with available cash, to redeem our $400 million aggregate principal amount of 8.25% senior subordinated notes due March 1, 2018 (the "2018 Notes") at a price of 102.063% of the principal amount and to pay fees and expenses related to the offering.

We incurred approximately $6.3 million of debt issuance costs in conjunction with these transactions, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes.

The 2023 Notes require semiannual interest payments on May 15 and November 15. The 2023 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our senior secured revolving credit facility. The 2023 Notes are unsecured senior obligations and are subordinated to all of our existing and future secured debt, including our Credit Facility, to the extent of the value of the collateral securing such indebtedness.

We may redeem some or all of the 2023 Notes at any time, at our option, on or after November 15, 2019 for 103.063%, on or after November 15, 2020 for 101.531% and on or after November 15, 2021 for 100%, plus accrued and unpaid interest.

The holders of the 2023 Notes have the right to require us to repurchase all or a portion of the 2023 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.

The 2023 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all financial covenants as of June 27, 2020.

### Asset-Based Loan Facility Amendment

On September 27, 2019, we entered into a Second Amended and Restated Credit Agreement (“Amended Credit Agreement”). The Amended Credit Agreement amended and restated the previous credit agreement dated April 22, 2016 and continues to provide up to a $400.0 million principal amount senior secured asset-based revolving credit facility, with up to an additional $200 million principal amount available with the consent of the Lenders, as defined, if we exercise the accordion feature set forth therein (collectively, the “Amended Credit Facility”). The Amended Credit Facility now matures on September 27, 2024. We may borrow, repay and reborrow amounts under the Amended Credit Facility until its maturity date, at which time all amounts outstanding under the Credit Facility must be repaid in full.

The Amended Credit Facility is subject to a borrowing base, reduced capacity due to reserves and certain other restrictions. The borrowing base is calculated using a formula initially based upon eligible receivables and inventory minus certain reserves, and was $400 million as of June 27, 2020. The Amended Credit Facility also allows us to add real property to the borrowing base so long as the real property is subject to a first priority lien in favor of the Administrative Agent for the benefit of the Lenders. Proceeds of the Amended Credit Facility will be used for general corporate purposes. The Amended Credit Facility includes a $50 million sublimit for the issuance of standby letters of credit and an increased $40 million sublimit for short-notice borrowings. We incurred approximately $1.6 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal expenses. The debt issuance costs are being amortized over the term of the Amended Credit Facility. As of June 27, 2020, there were no borrowings outstanding and no letters of credit outstanding under the Credit Facility. There were other letters of credit of $3.2 million outstanding as of June 27, 2020. Subsequent to our quarter ended March 28, 2020, we borrowed $200 million under our revolving credit facility to increase financial flexibility while we navigate an uncertain COVID-19 economic environment. We repaid $200 million under our revolving credit facility prior to our quarter ended June 27, 2020.

Borrowings under the Amended Credit Facility bear interest at an index based on LIBOR or, at our option, the Base Rate (defined as the highest of (a) the SunTrust prime rate, (b) the Federal Funds Rate plus 0.50%, (c) one-month LIBOR plus 1.00%), plus, in either case, an applicable margin based on our consolidated senior leverage ratio and (d) 0.00%. Such applicable margin for LIBOR-based borrowings fluctuates between 1.00%-1.50% (previously between 1.25% and 1.50%) and was 1.00% as of June 27, 2020, and such applicable margin for Base Rate borrowings fluctuates between 0.00%-0.50% (previously 0.25%-0.50%), and was 0.00% as of June 27, 2020. An unused line fee shall be payable monthly in respect of the total amount of the unutilized Lenders’ commitments and short-notice borrowings under the Amended Credit Facility. Letter of credit fees at the applicable margin on the average undrawn and unreimbursed amount of letters of credit shall be payable monthly and a facing fee of 0.125% shall be paid on demand for the stated amount of each letter of credit. We are also required to pay certain fees to the administrative agent under the Amended Credit Facility. As of June 27, 2020, the applicable interest rate related to Base Rate borrowings was 3.3%, and the applicable interest rate related to LIBOR-based borrowings was 1.2%. Banks currently reporting information used to set LIBOR will stop doing so after 2021. Various parties, including government agencies, are seeking to identify an alternative rate to replace LIBOR. We are monitoring their efforts, and we will likely amend contracts to accommodate any replacement rate where it is not already provided.

The administering regulatory authority announced it intends to phase out London Interbank Offered Rate (LIBOR) by the end of 2021. We have both LIBOR-denominated and Euro Interbank Offer Rate (EURIBOR)-denominated indebtedness. Once LIBOR is phased out it will be replaced by an alternative method equivalent to LIBOR. Any legal or regulatory changes made in response to LIBOR’s future discontinuance may result in, among other things, a sudden or prolonged increase or decrease in LIBOR, a delay in the publication of LIBOR, or changes in the rules or methodologies in LIBOR. In addition, alternative methods to LIBOR may be impossible or impracticable to determine. The transition to alternatives to LIBOR could be modestly disruptive to the credit markets, and while we do not expect that the transition from LIBOR and risks related thereto will have a material adverse effect on our financing costs, it is still uncertain at this time.

The Amended Credit Facility continues to contain customary covenants, including financial covenants which require us to maintain a minimum fixed charge coverage ratio of 1.00:1.00 upon triggered quarterly testing (e.g. when availability falls below certain thresholds established in the agreement), reporting requirements and events of default. The Amended Credit Facility is secured by substantially all assets of the borrowing parties, including (i) pledges of 100% of the stock or other equity interest of each domestic subsidiary that is directly owned by such entity and (ii) 65% of the stock or other equity interest of each foreign subsidiary that is directly owned by such entity. We were in compliance with all financial covenants under the Credit Facility during the period ended June 27, 2020.

### Summarized Financial Information for Guarantors and the Issuer of Guaranteed Securities

In November 2015, Central (the "Parent/Issuer") issued $400 million aggregate principal amount of 6.125% senior notes due November 2023 (the "2023 Notes") and on December 14, 2017, Central issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes"). The 2023 Notes and 2028 Notes are fully and unconditionally guaranteed on a joint and several senior basis by each of our existing and future domestic restricted subsidiaries (the "Guarantors") which are borrowers under or guarantors of our senior secured revolving credit facility ("Credit Facility"). The 2023 Notes and 2028 Notes are unsecured senior obligations and are subordinated to all of our existing and future secured debt, including our Credit Facility, to the extent of the value of the collateral securing such indebtedness. There are no significant restrictions on the ability of the Guarantors to make distributions to the Parent/Issuer. Certain subsidiaries and operating divisions of the Company do not guarantee the 2023 or 2028 Notes and are referred to as the Non-Guarantors.

The Guarantors jointly and severally, and fully and unconditionally, guarantee the payment of the principal and premium, if any, and interest on the 2023 and 2028 Notes when due, whether at stated maturity of the 2023 and 2028 Notes, by acceleration, call for redemption or otherwise, and all other obligations of the Company to the holders of the 2023 and 2028 Notes and to the trustee under the indenture governing the 2023 and 2028 Notes (the "Guarantee"). The Guarantees are senior unsecured obligations of each Guarantor and are of equal rank with all other existing and future senior indebtedness of the Guarantors.

The obligations of each Guarantor under its Guarantee shall be limited to the maximum amount as will, after giving effect to all other contingent and fixed liabilities of such Guarantor and to any collections from or payments made by or on behalf of any other Guarantor in respect of the obligations of such Guarantor under the guarantee not constituting a fraudulent conveyance or fraudulent transfer under Federal or state law.

The Guarantee of a Guarantor will be released:

(1) upon any sale or other disposition of all or substantially all of the assets of that Guarantor (including by way of merger or consolidation), in accordance with the governing indentures, to any person other than the Company;

(2) if such Guarantor merges with and into the Company, with the Company surviving such merger;

(3) if the Guarantor is designated as an Unrestricted Subsidiary; or

(4) if the Company exercises its legal defeasance option or covenant defeasance option or the discharge of the Company's obligations under the indentures in accordance with the terms of the indentures.

The following tables present summarized financial information of the Parent/Issuer subsidiaries and the Guarantor subsidiaries. All intercompany balances and transactions between subsidiaries under Parent/Issuer and subsidiaries under the Guarantor have been eliminated. The information presented below excludes eliminations necessary to arrive at the information on a consolidated basis. In presenting the summarized financial statements, the equity method of accounting has been applied to the Parent/Issuer's interests in the Guarantor Subsidiaries. The summarized information excludes financial information of the Non-Guarantors, including earnings from and investments in these entities.

*(in thousands)*

| Summarized Statements of Operations | Nine Months Ended June 27, 2020 Parent/Issuer | Guarantors | Fiscal Year Ended September 28, 2019 Parent/Issuer | Guarantors |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $622,610 | $1,288,951 | $764,991 | $1,496,962 |
| Gross profit | $144,963 | $419,114 | $172,075 | $495,968 |
| Income (loss) from operations | $7,836 | $155,629 | $(9,819) | $162,725 |
| Equity in earnings of Guarantor subsidiaries | $120,159 | $— | $127,439 | $— |
| Net income (loss) | $(20,152) | $120,159 | $(32,775) | $127,439 |

*Summarized Balance Sheet Information*

*(in thousands)*

|  | As of June 27, 2020 Parent/Issuer | Guarantors | As of September 28, 2019 Parent/Issuer | Guarantors |
| --- | ---: | ---: | ---: | ---: |
| Current assets | $761,853 | $632,834 | $732,597 | $523,670 |
| Intercompany receivable from Non-guarantor subsidiaries | 31,666 | 61,346 | 37,544 | 61,333 |
| Other assets | 1,990,988 | 1,488,968 | $1,833,445 | $1,397,277 |
| Total assets | $2,784,507 | $2,183,148 | $2,603,586 | $1,982,280 |
| Current liabilities | $142,785 | $209,882 | $102,242 | $164,574 |
| Long-term debt | 693,915 | — | 693,037 | — |
| Other liabilities | 947,697 | 97,715 | 867,268 | 62,656 |
| Total liabilities | $1,784,397 | $307,597 | $1,662,547 | $227,230 |

### Off-Balance Sheet Arrangements

There have been no material changes to the information provided in our Annual Report on Form 10-K for the fiscal year ended September 28, 2019 regarding off-balance sheet arrangements.

### Contractual Obligations

There have been no material changes outside the ordinary course of business in our contractual obligations set forth in the Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources in our Annual Report on Form 10-K for the fiscal year ended September 28, 2019, except as set forth below.

In December 2019, performance-based criteria associated with the $6 million contingent consideration liability related to our fiscal 2017 acquisition of Segrest, Inc. were met and accordingly, the entire amount was released out of an independent escrow account to the former owners as of December 28, 2019.

### New Accounting Pronouncements

Refer to Footnote 1 in the notes to the condensed consolidated financial statements for new accounting pronouncements.

### Critical Accounting Policies, Estimates and Judgments

There have been no material changes to our critical accounting policies, estimates and assumptions or the judgments affecting the application of those accounting policies since our Annual Report on Form 10-K for the fiscal year ended September 28, 2019.

## Market risk

As filed, 164 characters.

There has been no material change in our exposure to market risk from that discussed in our Annual Report on Form 10-K for the fiscal year ended September 28, 2019.

## Controls and procedures

As filed, 1,556 characters.

(a) *Evaluation of Disclosure Controls and Procedures*. Our Chief Executive Officer and principal financial officer have reviewed, as of the end of the period covered by this report, the “disclosure controls and procedures” (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) that ensure that information relating to the Company required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported in a timely and proper manner and that such information is accumulated and communicated to our management, including our Chief Executive Officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based upon this review, such officers concluded that our disclosure controls and procedures were effective as of June 27, 2020.

(b) *Changes in Internal Control Over Financial Reporting*. Our management, with the participation of our Chief Executive Officer and our principal financial officer have evaluated whether any change in our internal control over financial reporting occurred during the third quarter of fiscal 2020. We implemented controls and a new lease accounting system related to the adoption of ASC 842 and the related financial statement reporting. There were no other changes in our internal control over financial reporting during the third quarter of fiscal 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 5,157 characters.

Except as set forth below, there have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year ended September 28, 2019.

***The COVID-19 pandemic has impacted how we are operating our business, and the duration and extent to which this will impact our future results of operations and overall financial performance remains uncertain.***

The outbreak of the COVID-19 virus in Wuhan, China in late 2019 and subsequent spread of the virus throughout the world has impacted our day-to-day operations and the operations of the vast majority of our customers, suppliers, and consumers. The World Health Organization’s March 2020 declaration of the COVID-19 outbreak as a global pandemic has resulted in authorities implementing numerous measures to contain the virus, including travel bans and restrictions, border closures, quarantines, shelter-in-place orders, and business limitations and shutdowns. COVID-19 has adversely affected and may continue to adversely affect how we and our customers are operating our businesses and overall demand for our products.

We have experienced varying impacts to our Garden and Pet businesses due to COVID-19. In March and April, we experienced increased demand in pet consumables due to consumers stocking up on products as the COVID-19 shelter-in-place mandates were implemented. We also saw reduced consumption on other items, such as live fish and live plants, due to in-store curtailments of foot traffic and limited access to outdoor garden departments. In May, state and county governments began phased reopenings of their local economies. Access to outdoor garden departments resulted in increased demand for our products in May and June. Additionally, as a result of shelter-in-place requirement periods, pet ownership significantly increased and we saw increased sales continue in May and June across our Pet segment portfolio. We also continued to see rapid increase in demand in the e-commerce channel.

Although our facilities have largely been exempt or partially exempt from government closure orders as essential businesses, to support the health and well-being of our employees, customers and communities, we are requiring a significant portion of our workforce to work remotely, and local and state governments in the United States and in the United Kingdom have imposed shelter-in-place requirements and certain travel restrictions, all of which have changed how we operate our business. For our employees who are not working remotely, we have taken several actions to ensure their safety, including instituting workplace safety measures and ensuring the availability of personal protective equipment. While we believe that such actions will help to ensure the safety of our employees, there is no guarantee that such actions will ultimately be successful.

We have experienced temporary closures of certain production facilities and distribution centers, though there has not been a material impact from a plant closure to date. At some of our facilities, we have experienced reduced productivity and increased employee absences, which we expect to continue during the current pandemic. The pandemic and near-term increase in demand for pet consumables have created operational challenges for our distribution network and impacted our ability to meet our normal fill rate standards. Our supply chain has been impacted by the rapid increase in demand and it is possible we will experience increased operational and logistics costs. We may experience additional disruptions in our supply chain as the pandemic continues, though we cannot reasonably estimate the potential impact or timing of those events, and we may not be able to mitigate such impact.

We anticipate many small customers may permanently close, and we may experience collection delinquencies as customers seek to preserve liquidity. Additionally, we have small company equity method investments, intangible assets and other long-lived assets whose value is dependent on cashflows. These investments and other assets could be impacted by the COVID-19 pandemic and, therefore, may be more susceptible to impairment. Our assessment of possible asset impairment involves numerous assumptions that involve significant judgment. As a result of the uncertainties associated with the COVID-19 pandemic, the shelter-in-place orders and the post COVID-19 economic recovery, these factors will be even more difficult to estimate. We recorded an impairment charge of $3.6 million in our third fiscal quarter and may be required to write off certain assets that could be material in future periods.

The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the severity and transmission rate of the virus, the extent and effectiveness of containment actions and the impact of these and other factors on our employees, independent contractors and customers and consumers. If we are not able to respond to and manage the impact of such events effectively, our business will be harmed.

Filed Aug 6, 2020.
Source: SEC EDGAR, the filing index for accession 0000887733-20-000012. Last ingested by Listed: Nov 10, 2026, 04:49 ET. No prices; not investment advice.
